Results 121 to 130 of about 4,299,415 (353)
Hyperorexia and Loss of Weight: A Psychosomatic Cause; Report of A Case [PDF]
John Brice Plass
openalex +1 more source
Fervidibacter sacchari is a member of the bacterial phylum Armatimonadota, only a few of which have been cultivated. It is a hyperthermophilic polysaccharide degradation specialist. We show that a secreted enzyme, Fsa02490Xyn, is an endoxylanase belonging to glycoside hydrolase family 10.
Nicole Torosian+10 more
wiley +1 more source
Correction to: Preventing Peterson’s space hernia using a BIO synthetic mesh
Adam Skidmore, Edo O. Aarts
doaj +1 more source
Rauvolfia vormitoria Effect on the Degradation of Aluminium Alloy in 2.5 M Hydrochloric Acid Solution [PDF]
The deterioration of aluminium alloy in 2.5 M hydrochloric acid in the presence Rauvolfia vormitoria extract was examined using both gasometric and gravimetric techniques.
Ajayi, O. O.+3 more
core
Loss of Weight and Metabolic Rate of Rats with Lesions in the Medial and Lateral Hypothalamus [PDF]
J. A. F. Stevenson, Donald G. Montemurro
openalex +1 more source
Nitric oxide‐forming nitrite reductases in the anaerobic ammonium oxidizer Kuenenia stuttgartiensis
Anammox bacteria remove fixed nitrogen from their environment via anaerobic ammonium oxidation (anammox) with nitrite as electron acceptor and dinitrogen gas as product. The first anammox step is the conversion of nitrite to nitric oxide by nitrite reductase.
Femke J. Vermeir+4 more
wiley +1 more source
WEIGHT LOSS OF CELLULOSE AND AQUATIC MACROPHYTES IN A CAROLINA BAY [PDF]
Edward J. Kormondy
openalex +1 more source
Two‐way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3
PAX5::CBFA2T3 (PAX5‐C) is a fusion protein of the B‐cell transcription factor, PAX5, and is found in B‐cell ALL. We propose a putative model of two‐way inhibition of PAX5 transcriptional activity by PAX5‐C. There are two ways of repression by PAX5‐C: DNA‐binding‐dependent way and HDAC‐dependent way, with either being sufficient for the repression. HDAC
Reina Ueno+12 more
wiley +1 more source
Background: In 2023, the Obesity Medicine Association (OMA) published “Compounded peptides: An Obesity Medicine Association Position Statement.” Since this publication, the use of compounded peptides for the treatment of obesity has continued to evolve ...
Harold Edward Bays+5 more
doaj +1 more source
We propose a context‐dependent model where the Duchenne muscular dystrophy (DMD) gene acts as a tumour suppressor in aggressive tumours and as an oncogene in less aggressive ones. We propose this model as a unified framework to explain the opposing survival associations with DMD expression and to guide experimental exploration of the dual role of DMD ...
Lee Machado+4 more
wiley +1 more source